BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/27/2018 4:40:10 AM | Browse: 969 | Download: 1726
 |
Received |
|
2018-07-02 01:47 |
|
Peer-Review Started |
|
2018-07-02 02:01 |
|
To Make the First Decision |
|
2018-07-19 07:51 |
|
Return for Revision |
|
2018-07-23 07:58 |
|
Revised |
|
2018-08-02 07:27 |
|
Second Decision |
|
2018-08-06 10:10 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-08-07 03:59 |
|
Articles in Press |
|
2018-08-07 03:59 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-10-23 00:23 |
|
Publish the Manuscript Online |
|
2018-10-27 04:40 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Adiponectin as a novel biomarker for liver fibrosis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Wanvisa Udomsinprasert, Sittisak Honsawek and Yong Poovorawan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Research Chair Grant from NSTDA |
P-15-50004 |
| Center of Excellence in Clinical Virology |
GCE 59-00930-005 |
| Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and Hospital |
|
|
| Corresponding Author |
Yong Poovorawan, MD, Professor, Center of Excellence in Clinical Virology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, 1873 Rama Ⅳ Road Patumwan, Bangkok 10330, Thailand. yong.p@chula.ac.th |
| Key Words |
Adiponectin; Hyperadiponectinemia; Liver fibrosis; Chronic liver disease; Biomarker |
| Core Tip |
Adiponectin plays a protective role against the development of liver fibrosis via inhibition of hepatic stellate cell activation, induced by specific signal transduction pathways. Among patients with chronic liver diseases (CLDs), hyperadiponectinemia is associated with the degree of liver fibrosis. The potential link between adiponectin and the limited progression of liver fibrosis has accelerated attraction in seeking adiponectin as a target for diagnostic detection tools and novel treatment methods. Nonetheless, additional current therapeutic and clinical trials of adiponectin in liver fibrosis are needed. In this context, we reviewed additional potential therapeutic applications of adiponectin in patients with various CLDs in the context of liver fibrosis. |
| Publish Date |
2018-10-27 04:40 |
| Citation |
Udomsinprasert W, Honsawek S, Poovorawan Y. Adiponectin as a novel biomarker for liver fibrosis. World J Hepatol 2018; 10(10): 708-718 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i10/708.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i10.708 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
